ABT

Abbott Laboratories · VIE:ABT

95.02 EUR−0.3200 −0.34%

Abbott Laboratories (VIE:ABT) last traded at 95.02 EUR, down 0.34% on the day. Over the past year the stock is down 11.64%. Its 52-week range is 70.10 to 113.14. It is in the Health Technology sector (Medical Specialties).

Key statistics

Open95.08

Day range94.72 – 95.08

52-week range70.10 – 113.14

Volume0

Average volume (10 days)12

Market cap (USD)183.77 B

P/E39.74

EPS (TTM) (USD)2.71

Dividend yield2.37%

Beta (1 year)−0.1772

Revenue (TTM) (USD)48.23 B

Employees115.00 K

Performance

+4.12%1 week

+10.10%1 month

+1.95%3 months

+27.51%6 months

−10.95%Year to date

−11.64%1 year

Technical reading

Bullish

Daily summary of what 11 oscillators and 15 moving averages show. See every indicator

Latest headlines

Notable analyst calls this week: Broadcom, Moderna and Abbott among top picksSeeking Alpha · 31 Oct 2026
HHS proposes changes to infant formula standardsSeeking Alpha · 29 Oct 2026
Abbott Initiates Pivotal Trial For Cephea™ Device, An Innovative Treatment For Mitral Heart Valve DiseaseReuters · 29 Oct 2026
Abbott Receives FDA Approval For First Device To Treat Leaks After Heart Valve ReplacementReuters · 28 Oct 2026
Abbott downgraded at Argus on guidance cutSeeking Alpha · 27 Oct 2026
Abbott Labs Cut to Hold From Buy by Argus ResearchDow Jones Newswires · 27 Oct 2026
Weekly Recap: Tighter EPS outlook and Exact Sciences in Cancer DiagnosticsTradingView · 26 Oct 2026
Abbott Labs Is Maintained at Overweight by Wells FargoDow Jones Newswires · 23 Oct 2026

Market data from TradingView’s public feed, delayed as the exchange requires. SuperCharting is charting software and gives no investment advice.